Upgrade to SI Premium - Free Trial

ProQR (PRQR) Surges Amid Positive 1/2 trial of QR-110, Plans to Progress to Pivotal Phase 2/3 Trial

September 5, 2018 9:14 AM
ProQR (NASDAQ: PRQR) surges 64% after the company announced results from a planned interim ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

FDA Momentum Movers Trader Talk

Next Articles